Sponsor

Novotech (Australia) Pty Limited

Clinical research sponsor

Published trials15
Recruiting shown2
Roles1
SourceClinicalTrials.gov

Clinical trials

15 shown
Evaluation of XYA02 in Patients With Advanced Solid TumorsNCT07670312 · collaborator · 2026-09-17
RECRUITING
Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy AdultsNCT06429930 · collaborator · 2025-04-11
RECRUITING
JX09 SAD/MAD in Healthy ParticipantsNCT06183671 · collaborator · 2024-01-18
UNKNOWN
Safety, Tolerability and Pharmacokinetics of L608 in Healthy AdultsNCT05938946 · collaborator · 2023-08-30
COMPLETED
Study of SPG302 in Healthy Volunteers and ALS ParticipantsNCT05882695 · collaborator · 2023-07-03
COMPLETED
A Study of ZT002 in Healthy ParticipantsNCT05491421 · collaborator · 2022-09-02
COMPLETED
A Study to Evaluate Effects of KN056 in Healthy ParticipantsNCT05385575 · collaborator · 2022-08-09
COMPLETED
A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients With Open-Angle Glaucoma or Ocular HypertensionNCT05456724 · collaborator · 2022-08-04
UNKNOWN
A Study to Evaluate the Safety and Tolerability of EXN407NCT04565756 · collaborator · 2020-11-05
COMPLETED
Study of Multiple Ascending Dose of KBL693 in Healthy ParticipantsNCT04307173 · collaborator · 2020-08-14
COMPLETED
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SNCT04430842 · collaborator · 2020-07-20
COMPLETED
LYT-100 in Patients With BCRLNCT04243837 · collaborator · 2020-03-01
TERMINATED
To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET DysregulationNCT04052971 · collaborator · 2019-08-01
COMPLETED
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced CancersNCT03212404 · collaborator · 2017-09-20
ACTIVE_NOT_RECRUITING
A Study of Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung CancerNCT01189968 · collaborator · 2010-09-01
COMPLETED

Sponsor roles

collaborator15

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.